SLC13A5 and fatty liver disease: For example, reduced plasma insulin and plasma triglyceride levels as well as an improvement of hepatic steatosis were observed in HFD-fed mice and rats in which liver-specific knockdown of Indy was accomplished using a low-dose of a chimeric anti-sense oligonucleotide (Pesta et al., 2015).